Prognosis of breast cancer after supraclavicular lymph node metastasis: Not a distant metastasis

Annals of Surgical Oncology

Volumn 13, Issue 11, 2006, Pages 1457-1465

  Chen, Shin Cheh ^a   Chang, Hsien Kun ^a   Lin, Yung Chang ^a   Leung, Wai Man ^a   Tsai, Chien Sheng ^a   Cheung, Yun Chung ^a   Hsueh, Swei ^a   See, Lai Chu ^b   Chen, Miin Fu ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Breast cancer; Metastasis; Neck dissection; Prognosis; Supraclavicular lymph node metastasis

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER RELAPSE; CANCER SURGERY; CANCER SURVIVAL; FOLLOW UP; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; NECK DISSECTION; POSTOPERATIVE COMPLICATION; PROGNOSIS; RECURRENT DISEASE; TIME SERIES ANALYSIS;

ADULT; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MEDICAL RECORDS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS;

EID: 33751002071     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-006-9012-1     Document Type: Article

References (34)

1. Fentiman IS, Lavelle MA, Caplan D, et al. The significance of supraclavicular recurrence of breast cancer. Cancer 1986; 57:908-10.
2. Halverson KJ, Perez CA, Kuske RR, et al. Survival following locoregional recurrence of breast cancer: univariate and multivariate analysis. Int J Radiat Oncol Biol Phys 1992; 23:285-91.
3. Debois JM. The significance of a supraclavicular node metastasis in patients with breast cancer. Strahlenther Onkol 1997; 173:1-12.
4. Mc Kinna F, Gothard L, Ashley S, et al. Lymphatic relapse in women with early breast cancer: a difficult management problem. Eur J Cancer 1999; 35:1065-9.
5. Fodor J, Tóth J, Major T, et al. Incidence and time of occurrence of regional recurrence in stage I-II breast cancer: value of adjuvant irradiation. Int J Radiat Oncol Biol Phys 1999; 44:281-7.
6. Kiricuta IC, Willner J, Kölbl O, et al. The prognostic significance of the supraclavicular lymph node metastases in breast cancer patients. Int J Radiat Oncol Biol Phys 1993; 28:387-93.
7. Signletary SE, Allred C, Ashley P, et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 2002; 20:3628-36.
8. Chen SC, Chen MF, Hwang TL, et al. Prediction of supra-clavicular lymph node metastasis in breast carcinoma. Int J Radiat Oncol Biol Phys 2002; 52:614-9.
9. Brito RA, Valero V, Buzdar AU, et al. Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastasis: the University of Texas M.D. Anderson Cancer Center experience. J Clin Oncol 2001; 19:628-33.
10. Olivotto IA, Chua B, Allan SJ, et al. Long-term survival of patients with supraclavicular metastases at diagnosis of breast cancer. J Clin Oncol 2003; 21:851-4.
11. Clemons M, Danson S, Hamilton T, et al. Locoregionally recurrent breast cancer: incidence, risk factors and survival. Cancer Treat Rev 2001; 27:67-82.
12. Voss M, Schneider JW, Apffelstaedt J. Axillary lymph node involvement in stage III breast cancer: treatment implications. J Surg Oncol 1999;(Suppl 71):162-6.
13. Axelsson CK, Rank F, Blichert-Toft M. Impact of axillary dissection on staging and regional control in breast tumor < or = 10 mm: the DBCG experience. Acta Oncol 2000; 39:283-9.
14. Tocchi A, Mazzoni G, Bettelli E, et al. Impact of axillary level I and II lymph node dissection on the therapy of stage I and II breast cancer. Panminerva Med 2001; 43:103-7.
15. Picrquin B, Mazeron JJ, Glaubiger D. Conservative treatment of breast cancer in Europe. Radiother Oncol 1986; 6:187-98.
16. Recht A, Gray R, Davidson NE, et al. Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group. J Clin Oncol 1999; 17:1689-700.
17. Ellis H, Colborn GL, Skandalakis JE. Surgical embryology and anatomy of the breast and its related anatomic structures. Surg Clin North Am 1993; 73:611-32.
18. Skandalakis LJ, Vohman MD, Skandalakis JE, et al. The axillary lymph nodes in radical and modified radical mastectomy. Am Surg 1979; 45:552-5.
19. Veronesi U, Luini A, Galimberti V, et al. Extent of metastatic axillary involvement in 1446 cases of breast cancer. Eur J Surg Oncol 1990; 16:127-33.
20. Nathanson SD, Wachna DL, Gilman D, et al. Pathways of lymphatic drainage from the breast. Ann Surg Oncol 2001; 8:837-43.
21. Nemoto T, Vana J, Bedwani RN, et al. Management and survival of female breast cancer: results of a national survey by the American College of Surgeons. Cancer 1980; 45:2917-24.
22. Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 1989; 63:181-7.
23. Tienhoven GV, Borger JH, Passchier DH, et al. The prognostic significance of the axillary apex biopsy in clinically operable breast cancer. Eur J Cancer 1995; 31:1965-8.
24. Cheng JC, Chen CM, Liu MC, et al. Locoregional failure of postmastectomy patients with 1-3 positive axillary lymph nodes without adjuvant radiotherapy. Int J Radiat Oncol 2002; 52:980-8.
25. Jatoi I, Hilsenbeck SG, Clark GM, et al. Significance of axillary lymph node metastasis in primary breast cancer. J Clin Oncol 1999; 17:2334-40.
26. Canavese G, Catturich A, Vecchio C, et al. Prognostic role of lymph-node level involvement in patients undergoing axillary dissection for breast cancer. Eur J Surg Oncol 1998; 24:104-9.
27. Zurrida S, Morabito A, Galimberti V, et al. Importance of the level of axillary involvement in relation to traditional variables in the prognosis of breast cancer. Int J Oncol 1999; 15:475-80.
28. Clemons M, Hamilton T, Goss P. Does treatment at the time of locoregional failure of breast cancer alter prognosis?. Cancer Treat Rev 2001; 27:83-97.
29. Lê MG, Arriagada R, Spielmann M, et al. Prognostic factors for death after an isolated local recurrence in patients with early-stage breast carcinoma. Cancer 2002; 94:2813-20.
30. Pergolizzi S, Settineri N, Russi EG, et al. Supraclavicular lymph node metastases (SLM) from breast cancer as only site of distant disease: has radiotherapy any role?. Anticancer Res 1997; 17:2303-8.
31. Khan SA, Stewart AK, Morrow M. Does aggressive local therapy improve survival in metastatic breast cancer?. Surgery 2002; 132:620-7.
32. Vicini FA, Kestin L, Huang R, et al. Does local recurrence affect the rate of distant metastases and survival in patients with early-stage breast carcinoma treated with breast-conserving therapy?. Cancer 2003; 97:910-9.
33. Noguchi M. Does regional treatment improve the survival in patients with operable breast cancer?. Br Cancer Res Treat 2002; 76:269-82.
34. Rauschecker H, Clarke M, Gatzemeier W, et al. Systemic therapy for treating locoregional recurrence in women with breast cancer. Cochrane Database Syst Rev 200; 1:4.